Thousand Oaks -- Amgen (NASDAQ:AMGN) will hold an investor webcast on Saturday, October 24, 2026, at 11:30 a.m. PT to discuss its oncology portfolio and selected data presented at the European Society of Medical Oncology Congress (ESMO) 2026.
Two senior executives lead Amgen's ESMO 2026 investor call
Murdo Gordon, executive vice president of Global Markets and Policy, and Jean-Charles Soria, senior vice president of oncology within Global Development, will lead the session. Other members of Amgen's management team will also take part.
Webcast is open to media, investors and the public
The event will be broadcast live over the internet and is open to members of the news media, investors and the general public. Presentation times, webcast availability and links are listed on Amgen's Investor Relations Events Calendar.
Amgen will archive the webcast and keep it available for replay for at least 30 days after the event.